H3. 3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin P Chen, J Zhao, Y Wang, M Wang, H Long, D Liang, L Huang, Z Wen, ... Genes & development 27 (19), 2109-2124, 2013 | 267 | 2013 |
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression W Su, HH Han, Y Wang, B Zhang, B Zhou, Y Cheng, A Rumandla, ... Cancer cell, 2019 | 192 | 2019 |
Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription Y Qiu, L Liu, C Zhao, C Han, F Li, J Zhang, Y Wang, G Li, Y Mei, M Wu, ... Genes & development 26 (12), 1376-1391, 2012 | 130 | 2012 |
Histone variants H2A. Z and H3. 3 coordinately regulate PRC2-dependent H3K27me3 deposition and gene expression regulation in mES cells Y Wang, H Long, J Yu, L Dong, M Wassef, B Zhuo, X Li, J Zhao, M Wang, ... BMC biology 16, 1-18, 2018 | 74 | 2018 |
Solution structure of the Pdp1 PWWP domain reveals its unique binding sites for methylated H4K20 and DNA Y Qiu, W Zhang, C Zhao, Y Wang, W Wang, J Zhang, Z Zhang, G Li, Y Shi, ... Biochemical Journal 442 (3), 527-538, 2012 | 60 | 2012 |
Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ... Cell reports 39 (1), 2022 | 46 | 2022 |
Dynamics of histone variant H3. 3 and its coregulation with H2A. Z at enhancers and promoters P Chen, Y Wang, G Li Nucleus 5 (1), 21-27, 2014 | 44 | 2014 |
Chromatin Assembly Factor 1 (CAF-1) facilitates the establishment of facultative heterochromatin during pluripotency exit L Cheng, X Zhang, Y Wang, H Gan, X Xu, X Lv, X Hua, J Que, T Ordog, ... Nucleic acids research 47 (21), 11114-11131, 2019 | 42 | 2019 |
Analysis of minor quantitative trait loci for eating and cooking quality traits in rice using a recombinant inbred line population derived from two indica cultivars with … B Yan, N Tondi Yacouba, J Chen, Y Wang, G Gao, Q Zhang, X Liu, Y He Molecular Breeding 34, 2151-2163, 2014 | 26 | 2014 |
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells D Kumar, S Gurrapu, Y Wang, SY Bae, PR Pandey, H Chen, J Mondal, ... Nature Cancer 5 (2), 262-282, 2024 | 24 | 2024 |
A heterotrimeric SMARCB1–SMARCC2 subcomplex is required for the assembly and tumor suppression function of the BAF chromatin-remodeling complex G Chen, H Zhou, B Liu, Y Wang, J Zhao, FG Giancotti, J Long Cell discovery 6 (1), 66, 2020 | 13 | 2020 |
750 Malat1 lncRNA controls metastatic reactivation of dormant breast cancer by immune evasion D Kumar, S Gurrapu, H Han, Y Wang, S Bae, H Chen, CJ Wu, F Giancotti Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 5 | 2020 |
SARS-CoV-2 exploits sexually dimorphic and adaptive IFN and TNFa signaling to gain entry into alveolar epithelium Y Wang, S Gurrapu, H Chen, S Laudato, E Caggiano, Y Jiang, HH Ling, ... bioRxiv, 2021.07. 23.453505, 2021 | 1 | 2021 |
Abstract LB023: Thyroid hormone receptor signaling promotes antiandrogen resistance and bone metastasis in prostate cancer Y Wang, G Harsha, D Kumar, J Curto, X Wang, F Giancotti Cancer Research 82 (12_Supplement), LB023-LB023, 2022 | | 2022 |
MP51-14 ORIGIN OF A MESENCHYMAL AND STEM-LIKE SUBTYPE OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER H Han*, Y Wang, YD Choi, N Cho, F Giancotti The Journal of Urology 203 (Supplement 4), e769-e769, 2020 | | 2020 |